+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Raltegravir"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
Isentress (raltegravir; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Isentress (raltegravir; Merck & Co) Drug Overview 2019

  • Report
  • June 2019
  • 14 Pages
  • Global
Tivicay (dolutegravir; ViiV Healthcare) Drug Overview 2019 - Product Thumbnail Image

Tivicay (dolutegravir; ViiV Healthcare) Drug Overview 2019

  • Report
  • June 2019
  • 26 Pages
  • Global
From
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Raltegravir is an antiretroviral drug used to treat HIV infection. It is a member of the integrase inhibitor class of drugs, which work by blocking the action of the HIV enzyme integrase, preventing the virus from replicating. Raltegravir is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who are at high risk of contracting the virus. Raltegravir is a widely used drug in the infectious diseases drugs market. It is used in combination with other antiretroviral drugs to treat HIV infection, and is also used to prevent HIV infection in people who are at high risk of contracting the virus. It is generally well tolerated and has few side effects. Some companies in the Raltegravir market include Merck & Co., Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, and ViiV Healthcare. Show Less Read more